In particular, significant FLG mutations were found in the high ROSig group, and studies suggest that loss of FLG function due to mutations may increase the risk of basal cell carcinoma, which may also be a mechanism for the worse prognosis of patients in the high ROSig group. The gene discussed is FLG; the disease is basal cell carcinoma.